Danbi Lee

3.2k total citations
131 papers, 2.2k citations indexed

About

Danbi Lee is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Danbi Lee has authored 131 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hepatology, 62 papers in Epidemiology and 24 papers in Oncology. Recurrent topics in Danbi Lee's work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (44 papers) and Hepatitis B Virus Studies (35 papers). Danbi Lee is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (44 papers) and Hepatitis B Virus Studies (35 papers). Danbi Lee collaborates with scholars based in South Korea, United States and Puerto Rico. Danbi Lee's co-authors include Han Chu Lee, Ju Hyun Shim, Young‐Suk Lim, Kang Mo Kim, Yung Sang Lee, Jihyun An, Young-Hwa Chung, Dong Jin Suh, Gi‐Ae Kim and Jonggi Choi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Danbi Lee

122 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danbi Lee South Korea 27 1.3k 985 437 338 283 131 2.2k
Yock Young Dan Singapore 31 1.5k 1.1× 1.7k 1.8× 398 0.9× 887 2.6× 976 3.4× 111 3.7k
William Sánchez United States 27 1.3k 1.0× 1.4k 1.4× 518 1.2× 1.1k 3.3× 386 1.4× 87 3.4k
Rey‐Heng Hu Taiwan 31 1.5k 1.2× 910 0.9× 754 1.7× 1.4k 4.1× 639 2.3× 213 3.5k
Harald Schrem Germany 23 945 0.7× 545 0.6× 540 1.2× 1.4k 4.2× 300 1.1× 135 2.4k
Cynthia A. Moylan United States 26 1.4k 1.1× 2.2k 2.3× 216 0.5× 688 2.0× 919 3.2× 75 3.6k
Daneng Li United States 24 1.1k 0.9× 685 0.7× 1.8k 4.1× 804 2.4× 286 1.0× 136 3.5k
Abha G. Singh United States 14 270 0.2× 663 0.7× 243 0.6× 514 1.5× 414 1.5× 29 2.5k
Linda Sher United States 29 1.2k 1.0× 539 0.5× 471 1.1× 1.6k 4.7× 557 2.0× 106 3.0k
Kelly W. Burak Canada 37 2.8k 2.2× 2.3k 2.3× 265 0.6× 1.3k 3.7× 94 0.3× 129 4.0k
Yuri Ito Japan 31 246 0.2× 770 0.8× 975 2.2× 680 2.0× 273 1.0× 153 3.0k

Countries citing papers authored by Danbi Lee

Since Specialization
Citations

This map shows the geographic impact of Danbi Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danbi Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danbi Lee more than expected).

Fields of papers citing papers by Danbi Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danbi Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danbi Lee. The network helps show where Danbi Lee may publish in the future.

Co-authorship network of co-authors of Danbi Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Danbi Lee. A scholar is included among the top collaborators of Danbi Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danbi Lee. Danbi Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hui, Rex Wan‐Hin, Byeong Geun Song, In Hye Song, et al.. (2025). Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 61(10). 1680–1691.
2.
Chung, Sung Won, Jin Sun Kim, Won‐Mook Choi, et al.. (2025). Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma. Clinical Cancer Research. 31(10). 2046–2055. 1 indexed citations
3.
Lee, Hye Won, Won‐Mook Choi, Danbi Lee, et al.. (2025). Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 61(8). 1310–1317.
4.
Jung, Jinhong, Jin‐hong Park, Jonggi Choi, et al.. (2024). Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma. Journal of Medical Imaging and Radiation Oncology. 69(1). 144–152. 1 indexed citations
5.
Chung, Sung Won, Ye‐Jee Kim, Jonggi Choi, et al.. (2024). Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study. The American Journal of Gastroenterology. 120(10). 2302–2311.
6.
Choi, Jonggi, Won‐Mook Choi, Danbi Lee, et al.. (2024). Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model. Liver International. 44(5). 1243–1252.
7.
Choi, Won‐Mook, Danbi Lee, Ju Hyun Shim, et al.. (2024). Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma. SHILAP Revista de lepidopterología. 24(2). 178–191. 1 indexed citations
8.
Choi, Won‐Mook, Ju Hyun Shim, Danbi Lee, et al.. (2023). Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. SHILAP Revista de lepidopterología. 23(1). 177–188. 6 indexed citations
9.
Choi, Won‐Mook, Danbi Lee, Ju Hyun Shim, et al.. (2023). Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment. Alimentary Pharmacology & Therapeutics. 59(4). 515–525. 6 indexed citations
10.
Jung, Jinhong, Danbi Lee, Ju Hyun Shim, et al.. (2022). Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. SHILAP Revista de lepidopterología. 22(2). 136–145. 11 indexed citations
11.
Choi, Jonggi, Danbi Lee, Ju Hyun Shim, et al.. (2022). The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment. Gut and Liver. 16(6). 964–975. 5 indexed citations
12.
Lim, Jihye, Seungbong Han, Danbi Lee, et al.. (2022). Identification of hepatic steatosis in living liver donors by machine learning models. Hepatology Communications. 6(7). 1689–1698. 5 indexed citations
13.
Choi, Won‐Mook, Ju Hyun Shim, Danbi Lee, et al.. (2022). Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B. Liver International. 42(7). 1517–1527. 26 indexed citations
14.
15.
16.
Choi, Won‐Mook, Ji Yoon Kim, Jonggi Choi, et al.. (2021). Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma. Liver International. 41(9). 2189–2199. 28 indexed citations
17.
Yoo, Changhoon, Hyo Jeong Kang, Min‐Hee Ryu, et al.. (2021). Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma. Liver International. 41(6). 1398–1408. 27 indexed citations
18.
Choi, Won‐Mook, Jonggi Choi, Danbi Lee, et al.. (2020). Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma. Hepatology Communications. 4(7). 1073–1086. 35 indexed citations
19.
Choi, Jonggi, Danbi Lee, Ju Hyun Shim, et al.. (2020). Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma. PLoS ONE. 15(3). e0229696–e0229696. 22 indexed citations
20.
Koo, Ja Eun, Danbi Lee, Eun Hee Kim, et al.. (2007). Primary gastrointestinal diffuse large B-cell lymphoma: A clinical analysis of 76 patients with special application of International Prognostic Index for survival. The Korean Journal of Internal Medicine. 72(1). 11–19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yock Young Dan Breakdown of academic impact, for papers by William Sánchez Breakdown of academic impact, for papers by Rey‐Heng Hu Breakdown of academic impact, for papers by Harald Schrem Breakdown of academic impact, for papers by Cynthia A. Moylan Breakdown of academic impact, for papers by Daneng Li Breakdown of academic impact, for papers by Abha G. Singh Breakdown of academic impact, for papers by Linda Sher Breakdown of academic impact, for papers by Kelly W. Burak Breakdown of academic impact, for papers by Yuri Ito
Rankless by CCL
2026